je.st
news
Tag: biotech
T3's Take 3: Amazon Wins, Equities Dip, Biotech Slumps
2015-07-24 23:26:33| Semiconductors - Topix.net
Today at T3 Live Jeff Cooper, author of the Daily Market Report made several calls today. Hi initiated a long swing on Agnico Eagles Mines , believing that that a major low for gold would be in no later than the end of July.
Merck, Baupost join $55M investment in early-stage biotech, RaNA
2015-07-24 18:09:58| Biotech - Topix.net
After selling his company Idenix Pharmaceuticals to Merck & Co. for $3.9 billion last August, Ronald Renaud has received support again from the New Jersey drug giant, this time in financing for his new company.
Tags: join
investment
biotech
merck
Premarket Biotech Digest: Novartis Earnings, Portola Lawsuits, Celgene's Orphan Drug
2015-07-23 11:13:42| Biotech - Topix.net
Xarelto, Eliquis and other anticoagulants that face products liability lawsuits have made deals with Portola, which is developing an antidote. One of the first anticoagulants, warfarin, was used as rat poison for 50 years before it began life as a blood thinner - and the only reason it did that was because a US Army sergeant who tried to kill himself with it was cured when treated with Vitamin K. Moral of the story- if you want to develop an anticoagulant, you better also develop its antidote, or you could bungle your way into multiple lawsuits.
Tags: drug
earnings
digest
biotech
Biotech ETFs: 3 Questions For IShares Investing Expert
2015-07-23 06:55:09| Biotech - Topix.net
TF investors in biotechnology stocks may be rattled by the nose-dive of the first heavyweight out of the earnings gate. , the $10 billion biotech exchange traded fund, has lost 0.8% in the past three trading sessions as 's reports this week, IBD spoke to Tushar Yadava, an iShares investment strategist, on whether the biotech sector has room to run: Tushar Yadava: Biotech investors entering for the first time are likely doing so in search of consistent growth - something the sector has delivered for a few years running.
Tags: questions
expert
investing
biotech
Court ruling clears way for Novartis' low-cost biotech drug
2015-07-21 22:41:33| Biotech - Topix.net
A federal appeals court has ruled that Novartis can begin selling its lower-cost copy of an Amgen Inc. drug in September, rejecting a bid to further delay the launch of the knock-off biotech medication. Novartis received federal approval in March to sell its cheaper copy of Amgen's Neupogen, which is used to boost blood cells in cancer patients.
Tags: court
drug
ruling
biotech
Sites : [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] next »